Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
3.940
-0.090 (-2.23%)
At close: Dec 5, 2025, 4:00 PM EST
3.830
-0.110 (-2.79%)
After-hours: Dec 5, 2025, 7:54 PM EST
Apyx Medical Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Apyx Medical stock has a target of 8.00, which predicts a 103.05% increase from the current stock price of 3.94.
Price Target: $8.00 (+103.05%)
Analyst Consensus: Buy
Analyst Ratings
According to 1 stock analyst, the rating for Apyx Medical is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citizens | Citizens | Hold → Buy Upgrades $8 | Hold → Buy | Upgrades | $8 | +103.05% | Nov 12, 2025 |
| BTIG | BTIG | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 17, 2024 |
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 16, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $8 → $5 | Buy | Maintains | $8 → $5 | +26.90% | Nov 10, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $4 → $4.5 | Buy | Maintains | $4 → $4.5 | +14.21% | Aug 11, 2023 |
Financial Forecast
Revenue This Year
52.19M
from 48.10M
Increased by 8.50%
Revenue Next Year
55.94M
from 52.19M
Increased by 7.18%
EPS This Year
-0.32
from -0.66
EPS Next Year
-0.36
from -0.32
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 54.1M | 60.9M | ||||
| Avg | 52.2M | 55.9M | ||||
| Low | 49.8M | 51.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 12.4% | 16.7% | ||||
| Avg | 8.5% | 7.2% | ||||
| Low | 3.5% | -1.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.30 | -0.32 | |
| Avg | -0.32 | -0.36 | |
| Low | -0.32 | -0.41 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.